See more : Lupin Limited (LUPIN.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Arjo AB (publ) (ARJO-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Arjo AB (publ), a leading company in the Medical – Distribution industry within the Healthcare sector.
- Fursys Inc. (016800.KS) Income Statement Analysis – Financial Results
- Tilak Ventures Limited (TILAK.BO) Income Statement Analysis – Financial Results
- Li-FT Power Ltd. (LIFFF) Income Statement Analysis – Financial Results
- transcosmos inc. (9715.T) Income Statement Analysis – Financial Results
- Equity Commonwealth (EQC-PD) Income Statement Analysis – Financial Results
Arjo AB (publ) (ARJO-B.ST)
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.98B | 9.98B | 9.07B | 9.08B | 8.93B | 8.22B | 7.69B | 7.81B | 8.12B | 7.57B |
| Cost of Revenue | 6.24B | 5.77B | 4.86B | 4.95B | 5.04B | 4.56B | 4.26B | 4.37B | 4.52B | 4.01B |
| Gross Profit | 4.74B | 4.21B | 4.21B | 4.13B | 3.89B | 3.66B | 3.43B | 3.44B | 3.59B | 3.56B |
| Gross Profit Ratio | 43.13% | 42.20% | 46.41% | 45.45% | 43.54% | 44.57% | 44.59% | 44.08% | 44.29% | 47.00% |
| Research & Development | 172.00M | 115.00M | 100.00M | 114.00M | 139.00M | 141.00M | 134.00M | 133.00M | 118.00M | 116.00M |
| General & Administrative | 1.46B | 1.33B | 1.22B | 1.26B | 1.22B | 1.22B | 1.14B | 1.02B | 1.04B | 937.00M |
| Selling & Marketing | 2.16B | 1.97B | 1.75B | 1.80B | 1.80B | 1.66B | 1.57B | 1.39B | 1.58B | 1.42B |
| SG&A | 3.63B | 3.30B | 2.98B | 3.05B | 3.02B | 2.88B | 2.71B | 2.41B | 2.61B | 2.36B |
| Other Expenses | 55.00M | 24.00M | 10.00M | 15.00M | 2.00M | 36.00M | -18.00M | -42.00M | 132.00M | 45.00M |
| Operating Expenses | 3.85B | 3.44B | 3.09B | 3.18B | 3.16B | 3.05B | 2.82B | 2.50B | 2.86B | 2.52B |
| Cost & Expenses | 10.10B | 9.21B | 7.95B | 8.14B | 8.20B | 7.61B | 7.08B | 6.87B | 7.39B | 6.53B |
| Interest Income | 28.00M | 16.00M | 4.00M | 5.00M | 8.00M | 4.00M | 9.00M | 4.00M | 4.00M | 2.00M |
| Interest Expense | 267.00M | 115.00M | 87.00M | 145.00M | 136.00M | 109.00M | 116.00M | 117.00M | 119.00M | 97.00M |
| Depreciation & Amortization | 1.06B | 985.00M | 956.00M | 970.00M | 998.00M | 663.00M | 641.00M | 667.00M | 681.00M | 635.00M |
| EBITDA | 1.96B | 1.73B | 2.07B | 1.82B | 1.68B | 1.17B | 936.00M | 1.46B | 1.23B | 1.59B |
| EBITDA Ratio | 17.86% | 18.68% | 22.83% | 20.91% | 19.44% | 15.91% | 17.35% | 21.84% | 17.44% | 22.16% |
| Operating Income | 884.00M | 691.00M | 1.08B | 866.00M | 671.00M | 493.00M | 281.00M | 781.00M | 540.00M | 953.00M |
| Operating Income Ratio | 8.05% | 6.92% | 11.87% | 9.54% | 7.52% | 6.00% | 3.66% | 10.00% | 6.65% | 12.59% |
| Total Other Income/Expenses | -244.00M | -94.00M | -88.00M | -164.00M | -129.00M | -98.00M | -102.00M | -110.00M | -115.00M | -92.00M |
| Income Before Tax | 640.00M | 597.00M | 989.00M | 702.00M | 542.00M | 395.00M | 179.00M | 671.00M | 425.00M | 861.00M |
| Income Before Tax Ratio | 5.83% | 5.98% | 10.90% | 7.73% | 6.07% | 4.81% | 2.33% | 8.59% | 5.24% | 11.38% |
| Income Tax Expense | 160.00M | 149.00M | 247.00M | 175.00M | 139.00M | 99.00M | 61.00M | 181.00M | 118.00M | 242.00M |
| Net Income | 480.00M | 449.00M | 742.00M | 526.00M | 403.00M | 296.00M | 118.00M | 490.00M | 307.00M | 619.00M |
| Net Income Ratio | 4.37% | 4.50% | 8.18% | 5.79% | 4.52% | 3.60% | 1.53% | 6.28% | 3.78% | 8.18% |
| EPS | 1.76 | 1.65 | 2.72 | 1.93 | 1.48 | 1.09 | 0.43 | 1.80 | 1.21 | 2.44 |
| EPS Diluted | 1.76 | 1.65 | 2.72 | 1.93 | 1.48 | 1.09 | 0.43 | 1.80 | 1.21 | 2.44 |
| Weighted Avg Shares Out | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 254.15M | 254.15M |
| Weighted Avg Shares Out (Dil) | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 272.37M | 254.15M | 254.15M |
Source: https://incomestatements.info
Category: Stock Reports